Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec:91:102499.
doi: 10.1016/j.coi.2024.102499. Epub 2024 Oct 31.

Tissue-resident memory cells in antitumoral immunity and cancer immunotherapy

Daniel Min  1 , Jacob Fiedler  2 , Niroshana Anandasabapathy  3
Affiliations
Review

Tissue-resident memory cells in antitumoral immunity and cancer immunotherapy

Daniel Min et al. Curr Opin Immunol. 2024 Dec.

Abstract

As cancer immunotherapy evolves, tissue-resident memory (TRM) cells remain key contributors to the antitumoral immune response due to their ability to mediate local tumor control, high expression of immune checkpoints, potential to respond to immunotherapy, and location across tissue sites where distal tumor metastases occur. This review synthesizes recent findings on the biology of TRM cells, their role in cancer, and their interactions with the tumor microenvironment. We also identify several critical research gaps, such as how mechanistic interrogation of TRM cell function is required for integration into therapeutics, proposing a focused research agenda to better exploit their potential.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest N.A. is a consultant for Genmab, Immunitas, Janssen Pharmaceuticals, 23&me, and Panther Life Sciences and is a member of the scientific advisory board of Shennon Bio.

References

    1. Gebhardt T, Palendira U, Tscharke DC, Bedoui S: Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance. Immunol Rev 2018, 283:54–76. - PubMed
    1. Jaiswal A, Verma A, Dannenfelser R, Meissen M, Tirosh I, Izar B, Kim TG, Nirschl CJ, Devi KSP, Olson WC, et al.: An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell 2022, 40:524–544.e5. - PMC - PubMed

    2. ** Using advanced computation scoring classifications, large bulk sequencing sets, and several single cell sequencing data sets, with a comprehensive mix of murine and human T cell differentiation programs, these authors set out to take an unbiased global view of T cell differentiation in tumor and consequences for melanoma survival and response to immune checkpoint blockade.

    1. Jansen CS, Prokhnevska N, Master VA, Sanda MG, Carlisle JW, Bilen MA, Cardenas M, Wilkinson S, Lake R, Sowalsky AG, et al.: An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 2019, 576:465–470. - PMC - PubMed
    1. Ramirez DE, Mohamed A, Huang YH, Turk MJ: In the right place at the right time: tissue-resident memory T cells in immunity to cancer. Curr Opin Immunol 2023, 83:102338. - PMC - PubMed

    2. ** Comprehensive review highlighting hallmark studies implicating TRM and TCM in the response to cancer.

    1. Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, Lieb DJ, Chen JH, Frederick DT, Barzily-Rokni M, et al.: Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. Cell 2018,175:998–1013.e20. - PMC - PubMed